Mir Hashim
Chief Tech/Sci/R&D Officer chez RANI THERAPEUTICS HOLDINGS, INC.
Fortune : 4 M $ au 31/03/2024
Profil
Mir Hashim is currently the Chief Scientific Officer & Director at Rani Therapeutics LLC.
He is also the Vice President-Research & Development at InCube Labs LLC since 2008.
Additionally, Dr. Hashim holds the position of Chief Scientific Officer at Rani Therapeutics Holdings, Inc. since 2021.
Previously, he worked as the Head-Pharmacology at GSK Plc.
Dr. Hashim holds a doctorate degree from Memorial University of Newfoundland, an undergraduate degree from Osmania University, and a graduate degree from the University of Hyderabad.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. 2,55% | 29/07/2021 | 786 392 ( 2,55% ) | 2 M $ | 31/03/2024 |
| 31/03/2024 | 374 119 ( inf% ) | 1 M $ | 31/03/2024 | |
| 31/03/2024 | 148 415 ( 0,57% ) | 461 571 $ | 31/03/2024 | |
| 31/03/2024 | 25 649 ( 0,09% ) | 79 768 $ | 31/03/2024 |
Postes actifs de Mir Hashim
| Sociétés | Poste | Début |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06/04/2021 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | - |
InCube Labs LLC
 InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | 01/09/2008 |
Anciens postes connus de Mir Hashim
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Formation de Mir Hashim
| Memorial University of Newfoundland | Doctorate Degree |
| Osmania University | Undergraduate Degree |
| University of Hyderabad | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| RANI THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
InCube Labs LLC
InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Health Technology |
